Uncover California |
FDA Panel Recommends Asthma Treatment Approval for Adults Only
Pharmacy Times (registration) "We recognize the advisory committee's thoroughness in reviewing the data related to Breo Ellipta for asthma,” said Darrell Baker, senior vice president and head of GSK's Global Respiratory Franchise, in a press release. “We will continue to work … GSK And Theravance: Implications Of The Advisory Panel Decision Breo Ellipta receives Mixed Views from FDA Panel |
View full post on asthma – Google News